echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cancer Cell Chinese scholars reveal the mechanism of action of Anti-PD-L1 immunotherapy combined with chemotherapy in triple-negative breast cancer

    Cancer Cell Chinese scholars reveal the mechanism of action of Anti-PD-L1 immunotherapy combined with chemotherapy in triple-negative breast cancer

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Breast cancer ranks first among female malignant tumors.



    On October 14, 2021, the international journal Cancer Cell published an online research titled "Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple negative breast cancer" from a Chinese scholar in the form of a Research Article.



    Figure 1 Project research plan


    By comparing the differences in the composition of tumors and peripheral blood immune cells of different responders in the combination therapy group, the researchers found that the tumor microenvironment of the responding patients was enriched in two groups of T cells with high expression of CXCL13 (CD8-CXCL13 and CD4-CXCL13).


     

    Figure 2 Dynamic changes of T cell subsets under different treatment options


    In addition, the researchers found that the tumor microenvironment of the responding patients was enriched in two groups of pro-inflammatory macrophages with high expression of CXCL9 and CXCL10, and there was a significant positive correlation between these two groups of pro-inflammatory macrophages and CXCL13+ T cells (Figure 3)



    Figure 3 Tumor microenvironment and characteristics of myeloid cells in peripheral blood of TNBC patients


    The tumor microenvironment is a complex ecosystem, in which innate immune and adaptive immune cells, stromal cells, cancer cells and their interactions constitute a fine regulatory network that together determine the occurrence and development of cancer



    Figure 4 Dynamic changes of B cells and DC subgroups and their association with CXCL13+ T cells


    The first author of the paper, Dr.


    It is reported that this study is the largest single-cell omics study on TNBC tumor-related immune cells in the world so far.


    Professor Liu Zhihua from Cancer Hospital of Chinese Academy of Medical Sciences, Professor Zhang Zemin from Peking University Biomedical Frontier Innovation Center (BIOPIC), Professor Ma Fei and Professor Xu Binghe from Cancer Hospital of Chinese Academy of Medical Sciences are the co-corresponding authors of the paper


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.